WHO ICTRP trial
ILYX-002 Pharmacokinetics in Healthy Volunteers
ACTRN12624001355561 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12624001355561 |
|---|---|
| Public title | ILYX-002 Pharmacokinetics in Healthy Volunteers |
| Scientific title | A Study of the Multiple-Dose Pharmacokinetics of ILYX 002 in Healthy Volunteers |
| Primary sponsor | Iolyx Australia Pty Ltd |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | Dry-Eye Disease; Dry-Eye Disease;Eye - Diseases / disorders of the eye |
| Interventions | ILYX-002 (0.3%) is a sterile, isotonic, preservative-free topical ophthalmic suspension. ILYX-002 will be administered by designated, unmasked site staff to the participant twice a day for 7 days plus a single dose in the morning on Day 8… |
| Registration date | Dec 11, 2024 |
| Target size | 16 |
| Secondary IDs | ILYX-002-101 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: